Levi Strauss & Co. (NYSE:LEVI) Major Shareholder E. Haas Jr. Family Fund Peter Sells 145,662 Shares

Levi Strauss & Co. (NYSE:LEVI) major shareholder E. Haas Jr. Family Fund Peter sold 145,662 shares of the business’s stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $24.01, for a total transaction of $3,497,344.62. Following the completion of the sale, the insider directly owned 145,662 shares in the company, valued at approximately $3,497,344.62. This trade represents a 50.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

E. Haas Jr. Family Fund Peter also recently made the following trade(s):

• On Wednesday, May 27th, E. Haas Jr. Family Fund Peter sold 4,338 shares of Levi Strauss & Co. stock. The shares were sold at an average price of $24.00, for a total transaction of $104,112.00.

Levi Strauss & Co. Stock Performance

NYSE LEVI opened at $24.02 on Friday. The company’s 50 day moving average is $22.23 and its 200-day moving average is $21.33. Levi Strauss & Co. has a 12-month low of $16.50 and a 12-month high of $24.82. The company has a quick ratio of 0.97, a current ratio of 1.58 and a debt-to-equity ratio of 0.48. The firm has a market cap of $9.24 billion, a P/E ratio of 15.30, a price-to-earnings-growth ratio of 1.83 and a beta of 1.34.

Levi Strauss & Co. (NYSE:LEVI) last posted its quarterly earnings results on Tuesday, April 7th. The blue-jean maker reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.05. Levi Strauss & Co. had a net margin of 9.52% and a return on equity of 25.35%. The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.65 billion. During the same quarter in the previous year, the firm posted $0.38 earnings per share. The company’s quarterly revenue was up 14.1% compared to the same quarter last year. Sell-side analysts predict that Levi Strauss & Co. will post 1.5 earnings per share for the current year.

Levi Strauss & Co. Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 6th. Investors of record on Wednesday, April 22nd were issued a dividend of $0.14 per share. This represents a $0.56 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend was Wednesday, April 22nd. Levi Strauss & Co.’s dividend payout ratio is 35.67%.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on LEVI. Raymond James Financial reaffirmed an “outperform” rating and set a $25.00 target price on shares of Levi Strauss & Co. in a report on Monday, May 4th. Weiss Ratings raised shares of Levi Strauss & Co. from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, May 6th. TD Cowen reaffirmed a “buy” rating and set a $28.00 target price on shares of Levi Strauss & Co. in a report on Wednesday, May 27th. Wall Street Zen raised shares of Levi Strauss & Co. from a “hold” rating to a “strong-buy” rating in a report on Saturday, April 11th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $28.00 target price on shares of Levi Strauss & Co. in a report on Wednesday, April 8th. Thirteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $26.79.

Hedge Funds Weigh In On Levi Strauss & Co.

A number of institutional investors have recently made changes to their positions in the stock. Wells Fargo & Company MN increased its holdings in shares of Levi Strauss & Co. by 0.4% in the 4th quarter. Wells Fargo & Company MN now owns 132,304 shares of the blue-jean maker’s stock worth $2,744,000 after buying an additional 465 shares during the last quarter. Figure 8 Investment Strategies LLC increased its holdings in shares of Levi Strauss & Co. by 1.2% in the 4th quarter. Figure 8 Investment Strategies LLC now owns 50,939 shares of the blue-jean maker’s stock worth $1,056,000 after buying an additional 583 shares during the last quarter. Jones Financial Companies Lllp increased its holdings in shares of Levi Strauss & Co. by 10.3% in the 3rd quarter. Jones Financial Companies Lllp now owns 6,553 shares of the blue-jean maker’s stock worth $151,000 after buying an additional 614 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in shares of Levi Strauss & Co. by 2.4% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 26,732 shares of the blue-jean maker’s stock worth $575,000 after buying an additional 638 shares during the last quarter. Finally, US Bancorp DE increased its holdings in shares of Levi Strauss & Co. by 260.5% in the 3rd quarter. US Bancorp DE now owns 1,121 shares of the blue-jean maker’s stock worth $26,000 after buying an additional 810 shares during the last quarter. Institutional investors own 69.14% of the company’s stock.

Levi Strauss & Co. Company Profile

Levi Strauss & Co is a global apparel company best known for its denim jeans and casual wear. Founded in 1853 in San Francisco by Bavarian immigrant Levi Strauss, the company pioneered the modern blue jean with the introduction of rivet-reinforced work pants. Over its more than 160-year history, Levi Strauss has evolved into a lifestyle brand, offering a broad portfolio that includes denim for men, women and children, as well as tops, outerwear, footwear and accessories.

The company’s flagship label, Levi’s®, is recognized worldwide for its iconic styles such as the 501® Original Fit Jeans, while additional brands, including Dockers®, Target core metric, and Denizen® by Levi’s, cater to diverse price points and consumer segments.